Neurotoxicity by Cefepime: Case-Control Study
Background: Cefepime is a fourth-generation cephalosporin widely used for empiric treatment of severe infections. Neurotoxicity by cefepime have been reported due to γ-aminobutyric acid A receptor inhibition or other mechanisms. The aim of this study was to evaluate the risk factors for cefepime-ind...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Neurocritical Care Society
2014-12-01
|
Series: | Journal of Neurocritical Care |
Subjects: | |
Online Access: | http://www.e-jnc.org/upload/pdf/jnc-7-2-104.pdf |